Revenue, 2025

USD 1.45 Billion

Forecast, 2035

USD 2.83 Billion

CAGR, 2026-2035

6.9%

Report Coverage

Global

Membrane Oxygenators Market Trends for 2026

The global membrane oxygenators market size was estimated at USD 1.45 billion in 2025 and is predicted to increase from USD 1.55 billion in 2026 to approximately USD 2.83 billion by 2035, expanding at a CAGR of 6.9% from 2026 to 2035. The market is expanding because of the growing need for advanced life-support devices in cardiac surgeries, emergency care, and severe respiratory treatment.

Key Takeaways

• Membrane oxygenators market to crossed USD 1.55 billion by 2026.
• Market projected at USD 2.83 billion by 2035.
• CAGR of 6.9% expected in between 2026 to 2035.
• North America dominated the membrane oxygenators market with a share of 34% in 2025.
• Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
• By product type, the hollow fiber membrane oxygenators segment dominated the market with a revenue share of 88% in 2025 and is expected to grow at the fastest CAGR of 6.90% during the forecast period.
• By material, the polypropylene (PP) segment led the market with a share of 46% in 2025.
• By material, the polymethylpentene (PMP) segment held the second-largest share of 42% of the market in 2025 and is expected to grow at the fastest CAGR of 8.20% in the market during the forecast period.
• By application, the cardiopulmonary bypass surgery segment held a dominant share of 52% in 2025.
• By application, the extracorporeal membrane oxygenation (ECMO) segment held the second-largest share of 38% of the membrane oxygenators market in 2025 and is expected to grow at the fastest CAGR of 8.50% in the market during the forecast period.
• By age group, the adult segment dominated the market with a revenue share of 68% in 2025.
• By age group, the neonatal segment held 12% of the market share in 2025 and is expected to grow at the fastest CAGR of 7.60% during the forecast period.
• By end user, the hospitals segment held the largest market share of 72% in 2025.
• By end user, the cardiac centers segment held the second-largest share of 18% of the market in 2025 and is expected to grow at the fastest CAGR of 7.1% in the market during the forecast period.

Breathing Growth: What’s Driving the Membrane Oxygenators Market?

The membrane oxygenator is a medical device that temporarily performs the function of the lungs by supplying oxygen to the blood and removing carbon dioxide through a special membrane. The membrane oxygenators market is growing due to the rising prevalence of cardiovascular and respiratory disorders, increasing use of ECMO in critical care, and a growing number of cardiac surgeries worldwide. Technological advancements in hollow fiber oxygenators and improved hospital infrastructure are further supporting adoption. Additionally, the rising geriatric population and demand for advanced life-support systems continue to accelerate market expansion.

How Can AI Affect the Membrane Oxygenators Market?

AI can influence the market by enabling smarter patient monitoring, early risk detection, and real-time support for clinical decisions during ECMO and cardiac procedures. It also improves device efficiency, helps personalize treatment plans, and encourages the adoption of advanced oxygenation systems across hospitals and intensive care units.

Trend and Future Outlook of the Membrane Oxygenators Market

Growing demand for critical care support

The increasing number of patients requiring cardiac surgery and respiratory assistance is driving demand for membrane oxygenators. Hospitals are expanding intensive care capabilities, which is expected to support long-term market growth and wider adoption of advanced oxygenation systems.

Innovation in device design and performance

Future trends include more compact, efficient, and biocompatible oxygenators that improve blood oxygen exchange while minimizing complications. Continuous product innovation is likely to enhance treatment outcomes and increase usage across both adult and pediatric care settings.

Expansion across developing healthcare markets

Emerging economies are investing more in hospital infrastructure and advanced life-support technologies. As access to specialized critical care improves, these regions are expected to create strong future growth opportunities for membrane oxygenator manufacturers.

 Key Indicators and Highlights

Segmental Insights

By Product Type Insights

The Hollow Fiber Membrane Oxygenators Segment Dominated the Market in 2025

The hollow fiber membrane oxygenators segment dominated the membrane oxygenators market with shares of 88% in 2025 and is expected to grow at the fastest CAGR of 6.90% during the forecast period, because it offers efficient oxygen and carbon dioxide exchange, reliable performance during long procedures, and reduced risk of blood damage. Its extensive use in ECMO, cardiac surgeries, and critical care settings made it the most widely preferred product type across hospitals and specialty centers.

The flat sheet membrane oxygenators segment held the second largest market share of 12% in 2025 due to its stable performance, effective gas transfer, and suitability for specific cardiac and short-term extracorporeal procedures. Its simple structural design, ease of integration into existing systems, and continued use in specialized surgical applications supported its strong position in the market.

By Material Insights

The Polypropylene (PP) Segment Led the Market in 2025 with the Largest Share

The polypropylene (PP) segment led the membrane oxygenators market with shares of 46% in 2025 because of its high gas exchange efficiency, durability, and compatibility with blood-contact applications. Its lightweight nature and cost-effective manufacturing make it widely used in membrane oxygenators, particularly for ECMO and cardiac procedures, strengthening its leading position in the market.

The polymethylpentene (PMP) segment held the second largest market share of 42% in 2025 and is expected to grow at the fastest CAGR of 8.20% in the market during the forecast period due to its superior gas permeability, excellent biocompatibility, and long-term stability. Its low plasma leakage and high durability make it highly suitable for prolonged ECMO support and advanced critical care applications, driving faster adoption during the forecast period.

The silicon segment held 12% of the membrane oxygenators market share in 2025 due to its excellent flexibility, high oxygen permeability, and strong biocompatibility, making it suitable for efficient blood oxygenation applications. Its ability to maintain stable performance during prolonged procedures and reduce the risk of adverse reactions is increasing its use in specialized membrane oxygenators and advanced critical care systems.

By Application Insights

The cardiopulmonary bypass Surgery Segment Led the Market in 2025 with the Largest Share

The cardiopulmonary bypass surgery segment led the membrane oxygenators market with shares of 52% in 2025 due to the high volume of cardiac surgeries requiring temporary heart and lung support. Membrane oxygenators are essential in these procedures for maintaining blood oxygenation and circulation, making them widely used across hospitals and specialized cardiac care centers.

The extracorporeal membrane oxygenation (ECMO) segment held the second largest market share of 38% in 2025 and is expected to grow at the fastest CAGR of 8.50% in the market during the forecast period due to the rising use of advanced life-support systems for severe cardiac and respiratory failure. Increasing ICU admissions, growing awareness of ECMO therapy, and expanding critical care infrastructure are driving its rapid adoption during the forecast period.

The respiratory support segment held 10% of the membrane oxygenators market share in 2025 due to the increasing incidence of acute respiratory distress, chronic lung diseases, and critical care admissions requiring advanced oxygenation support. Rising demand for membrane oxygenators in ICU settings, especially for patients with severe respiratory failure, is boosting adoption. Improvements in hospital infrastructure and greater availability of life-support technologies are further supporting the segment’s growth.

By Age Group Insights

The Adult Segment held a dominant position in the Market in 2025

The adult segment held a dominant position in the membrane oxygenators market with a share of 68% in 2025 due to the higher prevalence of cardiovascular diseases, respiratory disorders, and cardiac surgeries among the adult and elderly populations. Adults account for the majority of ECMO and cardiopulmonary bypass procedures, leading to greater demand for membrane oxygenators. Additionally, rising age-related health complications and ICU admissions further strengthened this segment’s market leadership.

The pediatric segment held 20% of the market share in 2025 due to the rising diagnosis of congenital heart defects and neonatal respiratory disorders, and the increasing need for specialized critical care support in infants and children. Advancements in pediatric ECMO and oxygenation technologies, along with improved neonatal intensive care facilities, are further driving demand for membrane oxygenators in this segment.

The neonatal segment held 12% of the membrane oxygenators market share in 2025 and is expected to grow at the fastest CAGR of 7.60% in the market during the forecast period due to the rising incidence of premature births, neonatal respiratory distress, and congenital heart conditions. Increasing investments in neonatal intensive care units and advancements in specialized oxygenation systems for newborns are driving rapid growth in the segment during the forecast period.

By End User Insights

The Hospitals Segment Dominated the Market in 2025

The hospitals segment led the membrane oxygenators market with a share of 72% in 2025 due to the high volume of cardiac surgeries, ECMO procedures, and critical care treatments performed in hospital settings. Hospitals are equipped with advanced infrastructure, specialized surgical teams, and intensive care units, making them the primary users of membrane oxygenators. Rising patient admissions for cardiovascular and respiratory conditions further strengthened this segment’s leading position.

The cardiac centers segment held the second largest market share of 18% in 2025 and is expected to grow at the fastest CAGR of 7.1% in the market during the forecast period due to the increasing number of specialized heart surgeries, rising prevalence of cardiovascular diseases, and growing preference for dedicated cardiac care facilities. This advanced surgical infrastructure, expert specialists, and higher adoption of ECMO and bypass technologies are driving rapid market growth during the forecast period.

The ambulatory surgical centers (ASCs) segment held 10% of the membrane oxygenators market share in 2025 due to the rising preference for minimally invasive and same-day surgical procedures that reduce hospital stay and overall treatment costs. Increasing advancements in compact oxygenation systems and improved surgical capabilities at ASCs are supporting their adoption. Additionally, faster patient turnover and growing demand for cost-effective cardiac and respiratory interventions are driving segment growth.

Regional Insights

North America Leads the Breath-Tech Revolution

North America dominated the membrane oxygenators market with a share of 34% in 2025 due to its well-established healthcare infrastructure, high number of cardiac surgeries, and widespread use of ECMO in critical care. Strong investments in advanced medical technologies, the presence of key industry players, and increasing cases of heart and respiratory disorders further supported the region’s leading market position.

U.S. Market Trends

The U.S. membrane oxygenators market is expanding because of the increasing demand for advanced life-support systems in cardiac surgeries and intensive care. A growing burden of heart and lung disorders, strong hospital infrastructure, and continuous technological upgrades in oxygenation devices are further driving adoption and supporting steady market growth across the country.

Asia Pacific Emerges as the Fastest-Growing Hub

Asia Pacific is anticipated to grow at the fastest CAGR in the membrane oxygenators market during the forecast period due to rapid healthcare infrastructure development, rising investments in critical care facilities, and increasing cases of cardiovascular and respiratory diseases. Growing awareness of advanced oxygenation therapies, expanding hospital networks, and improving access to specialized surgical care are further accelerating market growth across the region.

India Market Trends

India is expected to grow at the fastest CAGR in the membrane oxygenators market during the forecast period due to the rapid expansion of healthcare infrastructure, rising cases of cardiac and respiratory disorders, and increasing access to advanced critical care treatments. Growing investments in hospitals, improving awareness of ECMO and oxygenation technologies, and a large patient population are further accelerating market demand across the country.

Supply Chain Analysis

R&D

• R&D in the membrane oxygenators market is centered on improving long-term blood compatibility, boosting oxygen and carbon dioxide exchange efficiency, and reducing priming volume, particularly for ECMO applications. Recent developments include advanced PMP materials and specially coated hollow fibers that help reduce plasma leakage and clot formation.
• Key Players: Medtronic, Terumo, Getinge, LivaNova, and Nipro. 

Clinical Trials

• Clinical trials in the membrane oxygenators market are focused on improving blood compatibility, lowering priming volume, and enhancing gas exchange performance compared to conventional models. These studies aim to improve patient safety, reduce complications, and support better outcomes in ECMO and cardiac surgery procedures.
• Key players: Medtronic, Terumo, Getinge, LivaNova, and Nipro

Patient Support and Services

• Patient support and services for membrane oxygenators, especially in ECMO care, involve continuous round-the-clock assistance from a multidisciplinary team that includes perfusion specialists, ICU nurses, and physicians. Key services include real-time circuit monitoring, anticoagulation control, nutritional management, and rehabilitation support.
• Key players: Medtronic, Getinge, Terumo, Fresenius Medical Care, and Nipro.

Top Vendors in Membrane Oxygenators Market & Their Offerings

SWOT Analysis

Strengths

• Essential for cardiac surgeries and ECMO support
• High demand in intensive care and emergency settings
• Continuous technological improvements in gas exchange efficiency
• Strong adoption across adult, pediatric, and neonatal care

Weaknesses

• High equipment and treatment costs
• Requires trained specialists and advanced hospital infrastructure
• Risk of complications such as clotting and blood damage
• Limited access in developing and low-resource regions

Opportunities

• Rising demand in emerging healthcare markets
• Growing use of ECMO for severe respiratory conditions
• Innovation in biocompatible and long-term use materials
• Expansion of critical care facilities worldwide

Threats

• Strict regulatory and approval requirements
• Competitive pricing pressure from regional manufacturers
• Risk of product-related complications and recalls
• Budget constraints in hospitals and healthcare systems

What are the Recent Developments in the Membrane Oxygenators Market?

• In October 2025, Cooper University Health Care’s ECMO program was honored with ELSO’s Gold Level recognition, showcasing its excellence in advanced life-support services, innovative treatment approaches, and strong multidisciplinary care for patients facing severe cardiac and respiratory conditions.
• In April 2025, AdventHealth Orlando, in collaboration with Orange County, introduced an ECMO CPR program aimed at improving survival rates and neurological recovery in cardiac arrest cases. The program ensures continuous circulation and oxygen support during patient transport and is strengthened by advanced EMS training and the hospital’s extensive ECMO capabilities.

Segments Covered in the Report

By Product Type

• Hollow Fiber membrane Oxygenators
• Microporous Hollow Fiber
• Dense Hollow Fiber
• Flat Sheet Membrane Oxygenators

By Material

• Polypropylene (PP)
• Polymethypentene (PMP)
• Silicon

By Application

• Cardiopulmonary Bypass Surgery
• Extracorporeal Membrane Oxygenation (ECMO)
• Veno Arterial ECMO (VA-ECMO)
• Veno Venous ECMO (VV-ECMO)
• Respiratory Support

By Age Group

• Adult
• Pediatric 
• Neonatal

By End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical centers (ASCs)

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA